Cost effectiveness of heart drugs varies widely, study says

Dobson, Roger
May 2007
BMJ: British Medical Journal (International Edition);5/5/2007, Vol. 334 Issue 7600, p922
Academic Journal
This article reports on a study that shows the cost effectiveness for treatments for coronary heart disease varies more than 100-fold. It found that the cost for each life year gained through the administration of aspirin and β blockers for secondary prevention after a heart attack worked out at less than £1,000 where the cost of statins used for primary prevention of heart attack in men aged 35-44 was about £ 70,000. The report also looked at the cost effectiveness of other treatments such as angiotensin converting enzyme (ACE) inhibitors, cardiac rehabilitation, coronary artery bypass graft surgery and angioplasty.


Related Articles

  • Short-Term Effects of Ivabradine in Patients with Chronic Stable Ischemic Heart Disease. Zaky, Hosam; Elzein, Hind; Alsheikh-Ali, Alawi A.; Al-Mulla, Arif // Heart Views;Apr-Jun2013, Vol. 14 Issue 2, p53 

    Introduction: Ivabradine is a novel selective If current inhibitor with anti-ischemic and antianginal activity. Objectives: To assess the effect of the selective If current inhibitor ivabradine on heart rate, angina pectoris, and functional capacity in stable patients with chronic coronary...

  • Therapy to improve PCI outcome. Wittkowsky, Ann K.; Gulbis, Brian E. // Drug Topics;12/16/2002, Vol. 146 Issue 23, pHSE18 

    Presents a question and answer advisory for the improvement of the outcome of percutaneous coronary intervention (PCI). Recommendations of taking clopidogrel prior to PCI intervention; Administration of aspirin together with clopidogrel; Introduction of ACE inhibitor for secondary prevention of...

  • Improve adherence to guideline medications in older patients who have undergone coronary bypass surgery.  // Drugs & Therapy Perspectives;Oct2012, Vol. 28 Issue 10, p24 

    The article focuses on the adherence to guidelines related to drugs in coronary bypass grafting (CABG) surgery old patients. It discusses changes in old patients and issues which should be addressed in such patients. It highlights that hospitals can implement a care plan and help patients to...

  • Aspirin benefits patients with stroke--but only just. Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);06/07/97, Vol. 314 Issue 7095, p1646 

    Discusses the therapeutic benefits that stroke patients derive from aspirin. Drop in recurrent ischemic strokes among patients administered heparin; Bias against heparin in the international stroke trial.

  • GP challenges use of aspirin for CHD.  // Pulse;6/24/2002, Vol. 62 Issue 25, p12 

    Reports on the challenge posed by British general practitioner Matthew Kiln on the use of long-term aspirin for patients with coronary heart disease. Issue raised by Kiln.

  • Optimal Medical Therapy for Coronary Artery Disease in 2011--Perspectives from the STICH Trial. Whayne, Thomas F.; Saha, Sibu P.; Quevedo, Karla; Mukherjee, Debabrata // Cardiovascular & Hematological Agents in Medicinal Chemistry;2011, Vol. 9 Issue 4, p269 

    Medical, percutaneous interventional, and surgical treatments for the management of coronary heart disease have progressed markedly during the past decade. There is evidence to suggest that for patients with stable coronary heart disease optimal medical therapy is equal in effectiveness for...

  • CABG or angioplasty? In these two trials it's close, but CABG gets the nod.  // Modern Medicine;Feb95, Vol. 63 Issue 2, p45 

    Presents an abstract of the article `A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease,' by C.W. Hamm, J. Reimers, et al from the periodical `The New England Journal of Medicine,' dated October 20, 1994.

  • Myocardial revascularization in 1997: Angioplasty versus... Faxon, David P. // American Family Physician;10/1/1997, Vol. 56 Issue 5, p1409 

    Focuses on angioplasty and coronary artery bypass graft surgery for the treatment of patients with coronary artery disease and severe ischemia. Information on the first coronary artery bypass graft surgery; Information on the Randomized Intervention Treatment of Angina (RITA) Trial, the first...

  • Percutaneous Transluminal Coronary Angioplasty in Octogenarians. Jeroudi, Mohamed O.; Kleiman, Neal S.; Minor, Steven T.; Hess, Kenneth R.; Lewis, John M.; Winters, William L.; Raizner, Albert E. // Annals of Internal Medicine;9/15/90, Vol. 113 Issue 6, p423 

    Assesses the safety and short- and long-term effectiveness of percutaneous transluminal coronary angioplasty in treating severe coronary artery disease in octogenarians. Determination of percent diameter stenosis; Complications that occurred in patients; Association of coronary bypass surgery...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics